Generics In a Federal Register notice, the US Food and Drug Administration has announced the rate for the Abbreviated New Drug Application (ANDA, relevant to regulatory approval of generic medicines), Prior Approval Supplement to an approved ANDA (PAS), Drug Master File (DMF), generic drug active pharmaceutical ingredient (API), and finished dosage form (FDF) facilities user fees related to the Generic Drug User Fee Program for fiscal year 2014. These fees will be effective from October 1, 2013, and would be reviewed after a year. 13 August 2013